Last 12 months
Inside the activity.
0 purchase rows · 39 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 14 |
| Dec 2025 | 0 | 8 |
| Jan 2026 | 0 | 5 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 9 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 12, 2025 Filed Mar 13, 2025 21:26 UTC |
Aebersold SarahChief Human Resources Officer
|
SaleCommon Stock | 7,324 | $26.34 | $192,914.16 |
DisclosureSEC source: 0001628280-25-012680 · wk-form4_1741901179.xml · nonDerivative · entry 2 Aebersold Sarah · CIK 0001837756 · Chief Human Resources Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 51,492 F2 · kind: The sales reported were effected pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 12-11-2024. Read SEC document |
| March 11, 2025 Filed Mar 13, 2025 21:26 UTC |
Berard ToddChief Marketing Officer
|
SaleCommon Stock | 1,577 | $25.00 | $39,425.00 |
DisclosureSEC source: 0001628280-25-012681 · wk-form4_1741901189.xml · nonDerivative · entry 1 Berard Todd · CIK 0001633186 · Chief Marketing Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 104,961 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 03-08-2024 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| March 11, 2025 Filed Mar 13, 2025 21:26 UTC |
Aebersold SarahChief Human Resources Officer
|
SaleCommon Stock | 1,091 | $25.00 | $27,275.00 |
DisclosureSEC source: 0001628280-25-012680 · wk-form4_1741901179.xml · nonDerivative · entry 1 Aebersold Sarah · CIK 0001837756 · Chief Human Resources Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 58,816 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 03-08-2024 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| March 11, 2025 Filed Mar 13, 2025 21:26 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
SaleCommon Stock | 1,597 | $25.00 | $39,925.00 |
DisclosureSEC source: 0001628280-25-012679 · wk-form4_1741901168.xml · nonDerivative · entry 1 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 260,601 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 03-08-2024 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| March 11, 2025 Filed Mar 13, 2025 21:26 UTC |
Foster Karen A.Chief Quality and Operations
|
SaleCommon Stock | 1,331 | $25.00 | $33,275.00 |
DisclosureSEC source: 0001628280-25-012678 · wk-form4_1741901158.xml · nonDerivative · entry 1 Foster Karen A. · CIK 0001683151 · Chief Quality and Operations 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 154,912 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 03-08-2024 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| March 11, 2025 Filed Mar 13, 2025 21:25 UTC |
Wichterman TroyChief Financial Officer
|
SaleCommon Stock | 4,151 | $25.00 | $103,775.00 |
DisclosureSEC source: 0001628280-25-012677 · wk-form4_1741901146.xml · nonDerivative · entry 1 Wichterman Troy · CIK 0001892616 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 116,809 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 03-08-2024 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| March 04, 2025 Filed Mar 5, 2025 22:14 UTC |
Werner SeanChief Technology Officer
|
SaleCommon Stock | 88 | $24.03 | $2,114.64 |
DisclosureSEC source: 0001628280-25-010568 · wk-form4_1741212833.xml · nonDerivative · entry 2 Werner Sean · CIK 0002047541 · Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,865 F2 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 09-01-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 22:13 UTC |
Foster Karen A.Chief Quality and Operations
|
SaleCommon Stock | 324 | $25.46 | $8,249.04 |
DisclosureSEC source: 0001628280-25-010566 · wk-form4_1741212823.xml · nonDerivative · entry 1 Foster Karen A. · CIK 0001683151 · Chief Quality and Operations 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 156,243 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 22:14 UTC |
Werner SeanChief Technology Officer
|
SaleCommon Stock | 136 | $25.46 | $3,462.56 |
DisclosureSEC source: 0001628280-25-010568 · wk-form4_1741212833.xml · nonDerivative · entry 1 Werner Sean · CIK 0002047541 · Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,953 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 22:13 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
SaleCommon Stock | 425 | $25.46 | $10,820.50 |
DisclosureSEC source: 0001628280-25-010565 · wk-form4_1741212812.xml · nonDerivative · entry 1 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 262,198 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 22:13 UTC |
Aebersold SarahChief Human Resources Officer
|
SaleCommon Stock | 284 | $25.46 | $7,230.64 |
DisclosureSEC source: 0001628280-25-010563 · wk-form4_1741212791.xml · nonDerivative · entry 1 Aebersold Sarah · CIK 0001837756 · Chief Human Resources Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 59,907 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 22:13 UTC |
Wichterman TroyChief Financial Officer
|
SaleCommon Stock | 660 | $25.46 | $16,803.60 |
DisclosureSEC source: 0001628280-25-010564 · wk-form4_1741212802.xml · nonDerivative · entry 1 Wichterman Troy · CIK 0001892616 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 120,960 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 22:13 UTC |
Berard ToddChief Marketing Officer
|
SaleCommon Stock | 424 | $25.46 | $10,795.04 |
DisclosureSEC source: 0001628280-25-010562 · wk-form4_1741212781.xml · nonDerivative · entry 1 Berard Todd · CIK 0001633186 · Chief Marketing Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 106,538 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| February 12, 2025 Filed Feb 14, 2025 22:47 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
SaleCommon Stock | 92 | $26.54 | $2,441.68 |
DisclosureSEC source: 0001628280-25-005844 · wk-form4_1739573226.xml · nonDerivative · entry 1 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 262,623 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-08-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| February 12, 2025 Filed Feb 14, 2025 22:46 UTC |
Foster Karen A.Chief Quality and Operations
|
SaleCommon Stock | 78 | $26.54 | $2,070.12 |
DisclosureSEC source: 0001628280-25-005842 · wk-form4_1739573206.xml · nonDerivative · entry 1 Foster Karen A. · CIK 0001683151 · Chief Quality and Operations 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 156,567 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-08-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| February 12, 2025 Filed Feb 14, 2025 22:47 UTC |
Wichterman TroyChief Financial Officer
|
SaleCommon Stock | 159 | $26.54 | $4,219.86 |
DisclosureSEC source: 0001628280-25-005843 · wk-form4_1739573216.xml · nonDerivative · entry 1 Wichterman Troy · CIK 0001892616 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 121,620 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 08-09-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| February 12, 2025 Filed Feb 14, 2025 22:46 UTC |
Berard ToddChief Marketing Officer
|
SaleCommon Stock | 102 | $26.54 | $2,707.08 |
DisclosureSEC source: 0001628280-25-005840 · wk-form4_1739573194.xml · nonDerivative · entry 1 Berard Todd · CIK 0001633186 · Chief Marketing Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 106,962 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-08-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| February 12, 2025 Filed Feb 14, 2025 22:46 UTC |
Aebersold SarahChief Human Resources Officer
|
SaleCommon Stock | 53 | $26.54 | $1,406.62 |
DisclosureSEC source: 0001628280-25-005839 · wk-form4_1739573185.xml · nonDerivative · entry 1 Aebersold Sarah · CIK 0001837756 · Chief Human Resources Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 60,191 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-08-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| January 06, 2025 Filed Jan 9, 2025 00:11 UTC |
Aebersold SarahChief Human Resources Officer
|
SaleCommon Stock | 240 | $27.02 | $6,484.80 |
DisclosureSEC source: 0001628280-25-000987 · wk-form4_1736381469.xml · nonDerivative · entry 1 Aebersold Sarah · CIK 0001837756 · Chief Human Resources Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 60,244 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| January 06, 2025 Filed Jan 9, 2025 00:11 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
SaleCommon Stock | 404 | $27.02 | $10,916.08 |
DisclosureSEC source: 0001628280-25-000986 · wk-form4_1736381459.xml · nonDerivative · entry 1 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 262,715 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| January 06, 2025 Filed Jan 9, 2025 00:10 UTC |
Berard ToddChief Marketing Officer
|
SaleCommon Stock | 343 | $27.02 | $9,267.86 |
DisclosureSEC source: 0001628280-25-000985 · wk-form4_1736381449.xml · nonDerivative · entry 1 Berard Todd · CIK 0001633186 · Chief Marketing Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 107,064 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| January 06, 2025 Filed Jan 9, 2025 00:10 UTC |
Foster Karen A.Chief Quality and Operations
|
SaleCommon Stock | 328 | $27.02 | $8,862.56 |
DisclosureSEC source: 0001628280-25-000983 · wk-form4_1736381429.xml · nonDerivative · entry 1 Foster Karen A. · CIK 0001683151 · Chief Quality and Operations 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 156,645 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| January 06, 2025 Filed Jan 9, 2025 00:10 UTC |
Wichterman TroyChief Financial Officer
|
SaleCommon Stock | 987 | $27.02 | $26,668.74 |
DisclosureSEC source: 0001628280-25-000982 · wk-form4_1736381417.xml · nonDerivative · entry 1 Wichterman Troy · CIK 0001892616 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 121,779 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| December 17, 2024 Filed Dec 19, 2024 22:19 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
SaleCommon Stock | 13,196 | $27.16 | $358,403.36 |
DisclosureSEC source: 0001628280-24-052104 · wk-form4_1734646743.xml · nonDerivative · entry 2 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 263,119 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 6-14-2024. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.62 to $27.48, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| December 16, 2024 Filed Dec 19, 2024 22:19 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
SaleCommon Stock | 7,604 | $27.33 | $207,817.32 |
DisclosureSEC source: 0001628280-24-052104 · wk-form4_1734646743.xml · nonDerivative · entry 1 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 276,315 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 6-14-2024. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.88 to $28.33, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| November 26, 2024 Filed Nov 29, 2024 22:30 UTC |
Wichterman TroyChief Financial Officer
|
SaleCommon Stock | 581 | $27.20 | $15,803.20 |
DisclosureSEC source: 0001628280-24-049480 · wk-form4_1732919407.xml · nonDerivative · entry 1 Wichterman Troy · CIK 0001892616 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 122,766 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| November 26, 2024 Filed Nov 29, 2024 22:30 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
SaleCommon Stock | 523 | $27.20 | $14,225.60 |
DisclosureSEC source: 0001628280-24-049479 · wk-form4_1732919397.xml · nonDerivative · entry 1 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 283,919 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| November 26, 2024 Filed Nov 29, 2024 22:29 UTC |
Berard ToddChief Marketing Officer
|
SaleCommon Stock | 349 | $27.20 | $9,492.80 |
DisclosureSEC source: 0001628280-24-049478 · wk-form4_1732919386.xml · nonDerivative · entry 1 Berard Todd · CIK 0001633186 · Chief Marketing Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 107,407 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| November 26, 2024 Filed Nov 29, 2024 22:29 UTC |
Aebersold SarahChief Human Resources Officer
|
SaleCommon Stock | 216 | $27.20 | $5,875.20 |
DisclosureSEC source: 0001628280-24-049477 · wk-form4_1732919376.xml · nonDerivative · entry 1 Aebersold Sarah · CIK 0001837756 · Chief Human Resources Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 60,484 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| November 26, 2024 Filed Nov 29, 2024 22:29 UTC |
Foster Karen A.Chief Quality and Operations
|
SaleCommon Stock | 252 | $27.20 | $6,854.40 |
DisclosureSEC source: 0001628280-24-049476 · wk-form4_1732919366.xml · nonDerivative · entry 1 Foster Karen A. · CIK 0001683151 · Chief Quality and Operations 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 156,973 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| November 18, 2024 Filed Nov 19, 2024 22:32 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
SaleCommon Stock | 17,604 | $20.05 | $352,960.20 |
DisclosureSEC source: 0001628280-24-048542 · wk-form4_1732055527.xml · nonDerivative · entry 4 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 284,442 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 06-14-2024. Read SEC document |
| November 15, 2024 Filed Nov 19, 2024 22:32 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
Exercise / conversionEmployee Stock Option · Derivative | 10,000 | $0.00 Strike: $2.06 | $0.00 |
DisclosureSEC source: 0001628280-24-048542 · wk-form4_1732055527.xml · derivative · entry 5 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2025-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: On May 4, 2015, the reporting person was granted an option to purchase 229,837 shares of common stock which vested 25% on the first anniversary of the grant date, and in 36 equal monthly installments thereafter. Read SEC document |
| November 15, 2024 Filed Nov 19, 2024 22:32 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
SaleCommon Stock | 15,000 | $21.17 | $317,550.00 |
DisclosureSEC source: 0001628280-24-048542 · wk-form4_1732055527.xml · nonDerivative · entry 3 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 302,046 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 06-14-2024. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.79 to $21.68, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| November 15, 2024 Filed Nov 19, 2024 22:32 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
SaleCommon Stock | 10,000 | $21.16 | $211,600.00 |
DisclosureSEC source: 0001628280-24-048542 · wk-form4_1732055527.xml · nonDerivative · entry 2 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 317,046 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 06-14-2024. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.82 to $21.68, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| November 15, 2024 Filed Nov 19, 2024 22:32 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
Exercise / conversionCommon Stock | 10,000 | $2.06 | $20,600.00 |
DisclosureSEC source: 0001628280-24-048542 · wk-form4_1732055527.xml · nonDerivative · entry 1 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 327,046 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 12, 2024 Filed Nov 14, 2024 23:38 UTC |
Berard ToddChief Marketing Officer
|
SaleCommon Stock | 91 | $26.34 | $2,396.94 |
DisclosureSEC source: 0001628280-24-047995 · wk-form4_1731627486.xml · nonDerivative · entry 1 Berard Todd · CIK 0001633186 · Chief Marketing Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 107,756 F1 · shares: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-08-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| November 12, 2024 Filed Nov 14, 2024 23:38 UTC |
Foster Karen A.Chief Quality and Operations
|
SaleCommon Stock | 66 | $26.34 | $1,738.44 |
DisclosureSEC source: 0001628280-24-047994 · wk-form4_1731627476.xml · nonDerivative · entry 1 Foster Karen A. · CIK 0001683151 · Chief Quality and Operations 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 157,225 F1 · shares: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-08-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| November 12, 2024 Filed Nov 14, 2024 23:37 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
SaleCommon Stock | 123 | $26.34 | $3,239.82 |
DisclosureSEC source: 0001628280-24-047993 · wk-form4_1731627466.xml · nonDerivative · entry 1 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 317,046 F1 · shares: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-08-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| November 12, 2024 Filed Nov 14, 2024 23:37 UTC |
Wichterman TroyChief Financial Officer
|
SaleCommon Stock | 147 | $26.19 | $3,849.93 |
DisclosureSEC source: 0001628280-24-047992 · wk-form4_1731627455.xml · nonDerivative · entry 1 Wichterman Troy · CIK 0001892616 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 123,347 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 08-09-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| October 31, 2024 Filed Jan 9, 2025 00:10 UTC |
DE GREEF RODERICKDirector · President and CEO
|
SaleCommon Stock | 46,896 | $23.43 | $1,098,773.28 |
DisclosureSEC source: 0001628280-25-000984 · wk-form4_1736381439.xml · nonDerivative · entry 1 DE GREEF RODERICK · CIK 0001241181 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 414,958 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 10-19-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| October 30, 2024 Filed Nov 1, 2024 23:02 UTC |
Aebersold SarahChief Human Resources Officer
|
SaleCommon Stock | 203 | $23.15 | $4,699.45 |
DisclosureSEC source: 0001628280-24-044815 · wk-form4_1730502121.xml · nonDerivative · entry 1 Aebersold Sarah · CIK 0001837756 · Chief Human Resources Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 60,700 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| October 30, 2024 Filed Nov 1, 2024 23:01 UTC |
Berard ToddChief Marketing Officer
|
SaleCommon Stock | 311 | $23.15 | $7,199.65 |
DisclosureSEC source: 0001628280-24-044814 · wk-form4_1730502110.xml · nonDerivative · entry 1 Berard Todd · CIK 0001633186 · Chief Marketing Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 107,847 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| October 30, 2024 Filed Nov 1, 2024 23:01 UTC |
Foster Karen A.Chief Quality and Operations
|
SaleCommon Stock | 277 | $23.15 | $6,412.55 |
DisclosureSEC source: 0001628280-24-044813 · wk-form4_1730502101.xml · nonDerivative · entry 1 Foster Karen A. · CIK 0001683151 · Chief Quality and Operations 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 157,291 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 01-03-23 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| October 30, 2024 Filed Nov 1, 2024 23:01 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
SaleCommon Stock | 547 | $23.15 | $12,663.05 |
DisclosureSEC source: 0001628280-24-044812 · wk-form4_1730502090.xml · nonDerivative · entry 1 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 317,169 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| October 30, 2024 Filed Nov 1, 2024 23:01 UTC |
Wichterman TroyChief Financial Officer
|
SaleCommon Stock | 894 | $23.15 | $20,696.10 |
DisclosureSEC source: 0001628280-24-044811 · wk-form4_1730502079.xml · nonDerivative · entry 1 Wichterman Troy · CIK 0001892616 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 123,494 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| October 16, 2024 Filed Oct 17, 2024 22:25 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
Exercise / conversionEmployee Stock Option · Derivative | 10,000 | $0.00 Strike: $2.06 | $0.00 |
DisclosureSEC source: 0001628280-24-043067 · wk-form4_1729203937.xml · derivative · entry 6 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2025-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: On May 4, 2015, the reporting person was granted an option to purchase 229,837 shares of common stock which vested 25% on the first anniversary of the grant date, and in 36 equal monthly installments thereafter. Read SEC document |
| October 16, 2024 Filed Oct 17, 2024 22:25 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
SaleCommon Stock | 10,000 | $23.17 | $231,700.00 |
DisclosureSEC source: 0001628280-24-043067 · wk-form4_1729203937.xml · nonDerivative · entry 4 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 317,716 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 06-14-2024. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.90 to $23.53, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| October 16, 2024 Filed Oct 17, 2024 22:25 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
Exercise / conversionCommon Stock | 10,000 | $2.06 | $20,600.00 |
DisclosureSEC source: 0001628280-24-043067 · wk-form4_1729203937.xml · nonDerivative · entry 3 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 327,716 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 15, 2024 Filed Oct 17, 2024 22:25 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
Exercise / conversionEmployee Stock Option · Derivative | 10,000 | $0.00 Strike: $2.06 | $0.00 |
DisclosureSEC source: 0001628280-24-043067 · wk-form4_1729203937.xml · derivative · entry 5 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 10,000 shares Expires 2025-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: On May 4, 2015, the reporting person was granted an option to purchase 229,837 shares of common stock which vested 25% on the first anniversary of the grant date, and in 36 equal monthly installments thereafter. Read SEC document |
| October 15, 2024 Filed Oct 17, 2024 22:25 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
SaleCommon Stock | 10,000 | $23.28 | $232,800.00 |
DisclosureSEC source: 0001628280-24-043067 · wk-form4_1729203937.xml · nonDerivative · entry 2 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 317,716 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 06-14-2024. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.01 to $23.49, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.